glp 1 immune system The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Antiinflammatory actions of glucagon-like peptide-1–based
Description
Maintaining muscle is critical for metabolism and long-term success, especially as appetite decreases
Clinical and Molecular Hepatology
Retatrutide Triple Agonist (GLP-1/GIP/GCG) for advanced metabolic research
Eli Lillys oral GLP-1 candidate orforglipron met all primary and secondary endpoints in a Phase 3 study of adults with type 2 diabetes, the
Dennis Bruemmer
